Skip to main content
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2012 Dec 10;2012:878365. doi: 10.1155/2012/878365

Inhibitory Activities of Cudrania tricuspidata Leaves on Pancreatic Lipase In Vitro and Lipolysis In Vivo

Young Sook Kim 1, Youngseop Lee 1, Junghyun Kim 1, Eunjin Sohn 1, Chan Sik Kim 1, Yun Mi Lee 1, Kyuhyung Jo 1, Sodam Shin 1, Yoojin Song 1, Joo Hwan Kim 2, Jin Sook Kim 1,*
PMCID: PMC3529879  PMID: 23365603

Abstract

To identify effective herb to treat obesity, we screened 115 herbal extracts for inhibition of porcine pancreatic lipase (triacylg-ycerol acylhydrolase, EC 3.1.1.3) activity in vitro. Of the extracts tested, Cudrania tricuspidata leaves exhibited the most pronounced inhibitory effect on lipase activity with an IC50 value of 9.91 μg/mL. Antilipid absorption effects of C. tricuspidata leaves were examined in rats after oral administration of lipid emulsions containing 50 or 250 mg  C. tricuspidata/kg body weight. Plasma triacylglycerol levels 2 h after the oral administration of emulsions containing C. tricuspidata were significantly reduced compared to the untreated group (P < 0.05). These results suggest that C. tricuspidata leaves may be useful for the treatment of obesity.

1. Introduction

Obesity is a significant risk factor for increased morbidity and mortality from cardiovascular disease and diabetes; however, it is also associated with many other medical conditions including cancer, liver and kidney diseases, sleep apnea, and depression [1]. The recent National Health and Nutrition Examination Survey showed that 68.0% of those studied were considered overweight (basal metabolic rate (BMI) ≥ 25) and 33.8% were obese (BMI ≥ 30) [2]. The inhibition of dietary fat absorption is a logical target for managing obesity, and pancreatic lipase is a key enzyme involved in triglyceride absorption in the small intestine. It is secreted from the pancreas and hydrolyzes triglycerides into glycerol and free fatty acids. Thus, inhibitors of digestive lipases are suggested to function as antiobesity agents [3]. Orlistat, which can be found in global markets, inhibits the action of gastrointestinal lipase and thus reduces absorption of dietary fat. However, it has serious side effects, such as steatorrhea, stomach pain, irregular menstrual periods, and headaches [4]. Recently, studies have searched for new lipase inhibitors in natural resources with minimal adverse effects. In a series of investigations to evaluate potential lipase inhibitors derived from plants, researchers showed that certain plant extracts significantly inhibited porcine pancreatic lipase in vitro [5, 6]. In this study, as a preliminary evaluation of natural antiobesity products, we tested 115 herbal extracts for inhibition of pancreatic lipase activity in vitro and verified the suppression of lipid absorption by C. tricuspidata leaves in vivo. The fruits of C. tricuspidata suppress development of atopic dermatitis in animal model and the roots of it exhibit immunomodulatory and anti-oxidant activities in vitro [7, 8]. These results show that C. tricuspidata leaves extracts have on lipase and dietary fat absorptionactivities and may be useful in the treatment of obesity and metabolic disease.

2. Material and Methods

2.1. Plant Materials and Chemicals

Herbs were collected from Republic of Korea from September 2005 to July 2009 and identified by Professor Kim, Division of Life Science, Gachon University, Republic of Korea. Samples were deposited at the Herbarium of Diabetic Complication Research Team, Korea Institute of Oriental Medicine. Porcine pancreatic lipase (type II), orlistat, and p-nitrophenyl butyrate were purchased from Sigma-Aldrich (St. Louis, MO, USA). All reagents were of biochemical grade.

2.2. Animals

Male Wistar rats (6 weeks of age) were purchased from Koatech (Kyungkido, Korea) and housed for 1 week in a 12-h/12-h light/dark cycle in a temperature- and humidity-controlled room. The animals were given free access to food and water. After adaptation to these conditions for 1 week, healthy animals were used in the present study. The Animal Studies Committee of Korea Institute of Orient Medicine approved the experimental protocol.

2.3. Preparation of Herbal Extracts

Dried and ground herbs (200 g) were extracted with 1 L of 80% EtOH 3 times by maceration. The extracts were concentrated and dried in vacuo at 40°C. Concentrated extracts were stored at −20°C for further studies. Extracts were dissolved in dimethyl sulfoxide at concentrations that in the total volume (3%) did not affect enzyme activity.

2.4. Measurement of Porcine Pancreatic Lipase Inhibitory Activity

The ability of the herbs to inhibit pancreatic lipase was measured using the method previously reported by Kim et al. [9, 10]. Briefly, an enzyme buffer was prepared by the addition of 6 μL porcine pancreatic lipase solution (Sigma-Aldrich) in buffer containing 10 mM MOPS (morpholinepropanesulphonic acid) and 1 mM EDTA, pH 6.8, to 169 μL Tris buffer (100 mM Tris-HC1 and 5 mM CaCl2, pH 7.0). Then, 20 μL of either the herbal extracts at the test concentration (0, 0.313, 0.625, 1.25, 2.5, 5, 7.5, 10, 50, and 100 μg/mL) or orlistat (Roche, Basel, Switzerland) were mixed with 175 μL enzyme buffer and incubated for 15 min at 37°C with 5 μL substrate solution (10 mM p-NPB (p-nitrophenylbutyrate) in dimethyl formamide); the enzymatic reactions were allowed to proceed for 15 min at 37°C. Lipase activity was determined by measuring the hydrolysis of p-NPB to p-nitrophenol at 405 nm using an ELISA reader (BIO-TEK, Synergy HT, Winooski, VT, USA). Inhibition of lipase activity was expressed as the percentage decrease in OD when porcine pancreatic lipase was incubated with the test materials. Lipase inhibition (%) was calculated according the following formula:

Inhibition(%)=100(BbAa×100), (1)

where A is the activity without inhibitor, a is the negative control without inhibitor, B is the activity with inhibitor, and b is the negative control with inhibitor. The results were expressed as an average (n = 3).

2.5. Estimation of Plasma Triacylglycerol after Oral Administration of Lipid Emulsion in Rats

Plasma triacylglycerol levels were estimated using the method previously reported by Kim et al. [11]. Rats (7 weeks of age, body weight 190 ~ 230 g) that had fasted overnight were orally administered 3 mL lipid emulsion consisting of corn oil (6 mL), cholic acid (80 mg), cholesteryloleate (2 g), and saline (6 mL) with or without C. tricuspidata leaves (at doses of 50 or 250 mg C. tricuspidata leaves/kg body weight). Blood was taken from the tail vein at 0, 1, 2, 3, and 4 h after oral administration of the lipid emulsion and centrifuged at 5500 ×g for 5 min to obtain the plasma. Triacylglycerol levels were determined using the Cleantech TS-s kit (ASANPHARM, Seoul, Korea).

2.6. Statistical Analysis

All experiments were repeated three times, and representative data are shown. Data are expressed as the mean ± S.D. Differences between groups were analyzed using a one-way ANOVA followed by the Tukey multiple comparison test (PRISM software, Graph Pad, CA, USA). Values of P < 0.05 were considered statistically significant.

3. Results and Discussion

3.1. Pancreatic Lipase Activity of Herbal Extracts

Currently, obesity is considered a global epidemic, and many medications have been studied and developed to treat this condition. However, there is presently only one drug—orlistat—globally approved for long-term treatment of overweight patients after sibutramine was withdrawn in January 2010 from the European market [12, 13]. Although this compound strongly inhibits the activity of pancreatic lipase, which is an important enzyme associated with fat digestion, orlistat may cause serious adverse effects on the gastrointestinal, nervous, endocrine, and renal systems and interferes with the absorption and effectiveness of many drugs and vitamins [4, 14]. Therefore, researching a safe and effective natural inhibitor of pancreatic lipase has been a major target for the development of new drugs to treat obesity [15]. Among them, extracts isolated from natural sources such as Sorbus commixta, Morus bombycis, Panax ginseng, and Ginkgo biloba have been reported as potential agents in pancreatic lipase inhibition action [1619]. Our previous studies have also identified some natural products as new pancreatic lipase inhibitors [11, 18, 19]. In this study, 115 herbal extracts were prepared from selected parts of plants and tested at various concentrations as inhibitors of pancreatic lipase. The lipase inhibitory effects of the extracts are indicated by percentage (%) and IC50 values (Table 1). Eighteen extracts had IC50 values less than 50 μg/mL, and of these extracts, three samples (i.e., the whole Solidago serotina plant, the branches and leaves of Acer mono, and the leaves of C. tricuspidata) had IC50 values less than 10 μg/mL. Notably, C. tricuspidata leaves exhibited an IC50 value of 9.91 μg/mL (Figure 1).

Table 1.

Lipase inhibitory activities of extracts from herbs.

Scientific name Family Part used Conc. (μg/mL) Inhibition (%)a IC50 (μg/mL)
2.5 41.76 ± 2.48
Solidago  serotina Compositae Whole plant 5 49.70 ± 1.44 5.16
7.5 55.70 ± 1.81
5 46.17 ± 3.03
Acer  mono Aceraceae Branch, leaf 7.5 48.87 ± 3.09 7.7
10 53.16 ± 0.93
5 26.55 ± 0.52
Cudrania  tricuspidata Moraceae Leaf 7.5 38.97 ± 2.92 9.91
10 50.72 ± 1.05
10 49.77 ± 1.00
Kalopanax  pictus Araliaceae Bark 50 70.52 ± 1.70 10.51
100 76.34 ± 0.36
5 32.34 ± 2.04
Cudrania  tricuspidata Moraceae Branch, stem 10 48.29 ± 1.19 13.8
50 65.83 ± 0.29
10 45.06 ± 1.81
Oenothera  odorata Onagraceae Whole plant 50 59.58 ± 0.70 23.34
100 61.07 ± 0.63
10 45.08 ± 4.01
Platycarya  strobilacea Juglandaceae Branch, stem 50 56.72 ± 1.74 25.51
100 61.74 ± 1.26
10 41.62 ± 7.54
Actinidia  arguta Actinidiaceae Fruit 50 59.30 ± 0.80 26.7
100 67.23 ± 3.20
10 41.72 ± 2.86
Tilia  amurensis Tiliaceae Branch, leaf 50 59.26 ± 0.55 28.5
100 67.17 ± 1.03
10 36.79 ± 0.82
Actinidia  arguta Actinidiaceae Stem 50 63.38 ± 2.42 28.51
100 66.84 ± 2.70
20 43.12 ± 4.05
Euscaphis  japonica Staphyleaceae Branch 30 50.91 ± 1.29 28.62
40 56.29 ± 2.10
10 34.08 ± 1.94
Actinidia  arguta Actinidiaceae Root 50 63.93 ± 1.94 31.34
100 71.03 ± 0.89
10 44.19 ± 3.68
Carpinus  cordata Betulaceae Branch, stem 50 54.25 ± 1.11 31.39
100 58.91 ± 1.62
10 41.57 ± 2.64
Rhus  sylvestris Anacardiaceae Branch, leaf 50 57.23 ± 4.33 32.14
100 57.43 ± 2.28
10 41.52 ± 1.71
Celtis  sinensis Ulmaceae Branch, stem 50 54.56 ± 0.52 35.89
100 54.09 ± 3.37
10 34.40 ± 2.70
Prunus  serrulata Rosaceae Branch, leaf 50 53.53 ± 0.62 42.55
100 56.43 ± 3.18
10 28.48 ± 4.40
Potentilla  fragarioides Rosaceae Whole plant 50 54.81 ± 2.36 42.58
100 61.88 ± 1.34
10 32.90 ± 4.37
Tilia  mandshurica Tiliaceae Flower, leaf 50 51.59 ± 2.07 48.21
100 52.74 ± 2.30
10 19.86 ± 2.15
Actinidia  arguta Actinidiaceae Stem, leaf, fruit 50 50.25 ± 2.65 54.09
100 56.92 ± 2.15
10 28.85 ± 6.19
Hypericum  ascyron Hypericaceae Whole plant 50 49.57 ± 5.42 56.12
100 57.57 ± 3.13
10 37.15 ± 0.50
Rhus  chinensis Anacardiaceae Branch, leaf 50 49.65 ± 0.66 56.9
100 52.06 ± 1.66
10 23.97 ± 2.01
Picrasma  quassioides Simaroubaceae Branch, stem 50 48.78 ± 0.80 60.47
100 54.89 ± 1.38
10 26.90 ± 1.18
Prunus  persica Rosaceae Branch, leaf 50 48.04 ± 0.94 62.12
100 56.27 ± 1.46
10 12.22 ± 5.84
Actinidia  arguta Actinidiaceae Root 50 45.58 ± 3.38 69.17
100 56.48 ± 1.93
10 24.96 ± 2.54
Spiraea  pubescens Rosaceae Branch, leaf, flower 50 47.25 ± 3.35 74.62
100 52.19 ± 1.37
10 17.77 ± 3.99
Tilia  mandshurica Tiliaceae Branch, stem 50 44.39 ± 2.14 79.67
100 54.07 ± 2.85
10 17.93 ± 2.59
Acer  ginnala Aceraceae Branch, leaf 50 43.30 ± 3.02 82.29
100 53.89 ± 2.92
10 20.95 ± 3.37
Elsholtzia  splendens Labiatae Root 50 44.64 ± 1.74 83.98
100 52.58 ± 1.67
10 28.75 ± 5.25
Staphylea  bumalda Staphyleaceae Branch, leaf 50 42.55 ± 2.40 84.28
100 53.45 ± 2.55
80 49.17 ± 1.04
Pinus  densiflora Pinaceae Stem 90 49.77 ± 3.57 87.58
100 52.63 ± 2.09
10 29.96 ± 8.94
Machilus  thunbergii Lauraceae Leaf, branch 50 45.82 ± 0.31 90.9
100 50.93 ± 0.00
10 27.34 ± 8.43
Deutzia  glabrata Saxifragaceae Branch, leaf, flower 50 42.85 ± 2.09 91.09
100 51.51 ± 1.46
10 22.19 ± 1.39
Indigofera  kirilowii Leguminosae Branch, leaf, flower 50 39.83 ± 0.73 94.98
100 51.24 ± 1.32
Opuntia  ficus-indica Opuntiacae Stem 100 28.17 ± 1.66 >100
Hibiscus  syriacus Malvaceae Root 100 13.95 ± 0.72 >100
Actinidia  arguta Actinidiaceae Bark 100 26.02 ± 8.63 >100
Euonymus  oxyphyllus Celastraceae Branch 100 47.50 ± 0.76 >100
Eucommia  ulmoides Eucommiaceae Branch, leaf 100 37.76 ± 0.89 >100
Asarum  sieboldii Aristolochiac Root 100 15.50 ± 5.18 >100
Bupleurum  longeradiatum Umbelliferae Whole plant 100 34.69 ± 2.52 >100
Plantago  asiatica Plantaginacea Root 100 −14.66 ± 4.59 >100
Alisma  plantago-aquatica Alismataceae Root 100 22.03 ± 4.65 >100
Duchesnea  chrysantha Rosaceae Whole plant 100 36.69 ± 1.07 >100
Cuscuta  japonica Convolvulaceae Whole plant 100 2.43 ± 1.75 >100
Clematis  apiifolia Ranunculaceae Stem, leaf, flower 100 −19.96 ± 1.10 >100
Prunus  serrulata Rosaceae Branch 100 43.47 ± 0.18 >100
Colocasia  antiquorum Araceae Aerial part 100 −12.08 ± 3.87 >100
Lespedeza  cuneata Leguminosae Aerial part 100 −8.62 ± 2.65 >100
Lespedeza  cuneata Leguminosae Root 100 −4.14 ± 1.86 >100
Mallotus  japonicas Euphorbiaceae Aerial part 100 11.45 ± 3.84 >100
Alisma  canaliculatum Alismataceae Aerial part 100 16.36 ± 2.85 >100
Alisma  canaliculatum Alismataceae Root 100 26.99 ± 0.41 >100
Magnolia  denudata Magnoliaceae Flowers 100 −5.01 ± 2.23 >100
Scopolia  japonica Solanaceae Stem, leaf 100 −10.52 ± 0.76 >100
Scopolia  japonica Solanaceae Root 100 −18.32 ± 1.18 >100
Chloranthus  japonicus Chloranthaceae Whole plant 100 31.04 ± 2.37 >100
Barbarea  orthoceras Cruciferae Whole plant 100 −27.85 ± 2.32 >100
Caulophyllum  robustum Berberidaceae Stem, leaf 100 −4.46 ± 3.06 >100
Caulophyllum  robustum Berberidaceae Root 100 −23.10 ± 6.27 >100
Carduus  crispus Compositae Stem, leaf 100 30.13 ± 3.47 >100
Carduus  crispus Compositae Flower 100 44.24 ± 2.47 >100
Styrax  japonica Styracaceae Flower 100 31.62 ± 4.47 >100
Cornus  controversa Cornaceae Branch, leaf 100 39.65 ± 5.62 >100
Cornus  controversa Cornaceae Flower 100 40.45 ± 0.66 >100
Magnolia  sieboldii Magnoliaceae Branch, leaf 100 4.84 ± 5.72 >100
Magnolia  sieboldii Magnoliaceae Flower 100 −7.03 ± 8.14 >100
Prunus  persica Rosaceae Fruit 100 27.35 ± 1.98 >100
Rhamnus  yoshinoi Rhamnaceae Branch, leaf 100 43.98 ± 7.76 >100
Erigeron  annuus Compositae Whole plant 100 26.14 ± 0.86 >100
Styrax  japonica Styracaceae Branch, leaf 100 27.88 ± 0.97 >100
Quercus  aliena Fagaceae Branch, leaf 100 45.95 ± 1.73 >100
Callicarpa  japonica Verbenaceae Branch, leaf 100 11.36 ± 2.56 >100
Ligustrum  obtusifolium Oleaceae Branch, leaf 100 4.18 ± 1.41 >100
Lindera  obtusiloba Lauraceae Branch, leaf 100 41.98 ± 1.40 >100
Lespedeza  bicolor Leguminosae Branch, leaf 100 47.02 ± 2.78 >100
Carpinus  laxiflora Betulaceae Branch, leaf 100 39.49 ± 5.62 >100
Machilus  thunbergii Lauraceae Bark 100 36.58 ± 3.17 >100
Hedera  rhombea Araliaceae Whole plant 100 29.92 ± 0.78 >100
Arenaria  serpyllifolia Caryophyllaceae Whole plant 100 13.09 ± 1.54 >100
Paulownia  coreana Paulowniaceae Flower 100 35.25 ± 1.77 >100
Thlaspi  arvense Brassicaceae Whole plant 100 0.32 ± 0.92 >100
Vicia  villosa Leguminosae Whole plant 100 28.71 ± 1.94 >100
Descurainia  pinnata Brassicaceae Whole plant 100 7.88 ± 1.21 >100
Ribes  fasciculatum Saxifragaceae Branch, leaf, fruit 100 33.67 ± 2.10 >100
Corydalis  speciosa Fumariaceae Whole plant 100 9.30 ± 3.47 >100
Clematis  fusca Ranunculaceae Whole plant 100 −1.24 ± 5.89 >100
Deutzia  parviflora Saxifragaceae Branch, leaf, stem, flower 100 34.77 ± 3.21 >100
Rosa  multiflora Rosaceae Branch, leaf, stem, flower 100 42.42 ± 0.26 >100
Parthenocissus  tricuspidata Vitaceae Leaf, stem 100 48.73 ± 1.62 >100
Chelidonium  majus Papaveraceae Whole plant 100 10.93 ± 1.55 >100
Platycarya  stobilacea Juglandaceae Leaf 100 47.97 ± 1.14 >100
Platycarya  stobilacea Juglandaceae Flower 100 46.63 ± 0.54 >100
Carpinus  cordata Betulaceae Leaf 100 45.84 ± 1.30 >100
Celtis  sinensis Ulmaceae Leaf 100 40.23 ± 0.47 >100
Orixa  japonica Rutaceae Leaf 100 −0.19 ± 2.17 >100
Orixa  japonica Rutaceae Branch, stem 100 15.79 ± 3.07 >100
Orixa  japonica Rutaceae Fruit 100 25.89 ± 5.92 >100
Picrasma  quassioides Simaroubaceae Leaf 100 40.51 ± 0.74 >100
Picrasma  quassioides Simaroubaceae Fruit 100 25.21 ± 2.08 >100
Tilia  mandshurica Tiliaceae Leaf 100 42.08 ± 1.27 >100
Aralia  cordata Araliaceae Whole plant 100 32.27 ± 4.39 >100
Viburnum  sargentii Caprifoliaceae Branch, leaf 100 27.00 ± 1.59 >100
Polygonatum  odoratum Liliaceae Root 100 36.72 ± 0.40 >100
Astragalus  membranaceus Leguminosae Root 100 −4.26 ± 0.91 >100
Pleuropterus  multiflorus Polygonaceae Root 100 −17.48 ± 1.88 >100
Torilis  japonica Umbelliferae Fruit 100 −20.02 ± 4.86 >100
Phaseolus  angularis Leguminosae Fruit 100 −58.89 ± 0.70 >100
Phaseolus  radiates Leguminosae Fruit 100 −98.96 ± 9.06 >100
Artemisia  scoparia Compositae Aerial part 100 −21.76 ± 3.22 >100
Solanum  tuberosum Solanaceae Tuber 100 −38.90 ± 4.60 >100
Brassica  juncea Cruciferae Leaf 100 −34.85 ± 7.98 >100
Arctium  lappa Compositae Root 100 −38.38 ± 7.90 >100
Cucumis  sativus Cucurbitaceae Fruit 100 −138.86 ± 0.64 >100
Diospyros  kaki Ebenaceae Fruit 100 −136.26 ± 6.37 >100
Artemisia  princeps Compositae Aerial part 100 12.82 ± 2.47 >100
0.0005 5.53 ± 3.21
Orlistat (positive control) 0.005 21.40 ± 10.76 0.036 (0.073 μM)
0.05 63.19 ± 7.04

aResults are the mean ± SD (n = 3).

Figure 1.

Figure 1

Inhibitory effect of Cudrania tricuspidata leaf extract on porcine pancreatic lipase. (a) Porcine pancreatic lipase activity at different concentrations of C. tricuspidata leaves. (b) Orlistat was used as a positive control. Data are the mean ± S.D. (n = 3).

3.2. Inhibitory Effect of C. tricuspidata on Lipolysis In Vivo

Next, we focused on C. tricuspidata on lipolysis in vivo. C. tricuspidata has been used as an important folk medicine for the treatment of cancer in Korea and has also been used as a traditional medicine for the treatment of hypertension, neuritis, and inflammation in Asia [2022]. To evaluate the antilipolytic effects of C. tricuspidata leaves in vivo, we analyzed plasma triacylglycerol levels after oral administration of lipid emulsions with or without the C. tricuspidata leaves to rats. Figure 2 shows plasma triacylglycerol levels after oral administration of lipid emulsion with or without C. tricuspidata as a function of time. After oral administration, low concentrations of C. tricuspidata (50 mg/kg body weight) reduced plasma triacylglycerol levels and high concentrations of C. tricuspidata (250 mg/kg body weight) delayed lipid absorption significantly; however, these effects were weaker than that of the positive control, orlistat.

Figure 2.

Figure 2

Inhibitory effect of Cudrania tricuspidata leaves on rat plasma triacylglycerol levels. Plasma triacylglycerol levels, at the time marked by an asterisk, significantly differ between the control and C. tricuspidata (250 mg/kg) groups (P < 0.05). Orlistat (a lipase inhibitor) was used as a positive control (P < 0.001 versus control).

C. tricuspidata is a rich source of xanthones and flavonoids, including cudraflavone C [23]. A recent study reported that cudraflavone C from Artocarpus nitidus inhibited pancreatic lipase activity (IC50 = 17.0 ± 0.7 μM) [24]. Thus, cudraflavone C may be a potential as one of active compounds for preventing and treating obesity.

4. Conclusion

In this paper, we screened 115 herbal extracts for inhibition of porcine pancreatic lipase to identify effective herb to treat obesity. C. tricuspidata leaves show the most pronounced effect on pancreatic lipase activity and are able to suppress dietary fat absorption in vivo. Up until now, C. tricuspidata leaves extracts have not been reported on lipase and dietary fat absorptionactivities. Thus, it is worthwhile to further investigate these extracts for their potential pharmacological effect in antiobesity and attempt should be made to characterize phytoactive compounds to be used as safer therapeutic agents in future.

Authors' Contribution

Y. S. Kim and Y. Lee contributed equally to this work.

Conflict of Interests

The authors declare no conflict of interests.

Acknowledgments

This research was supported by Grants (K11040 and K12040) from the Korea Institute of Oriental Medicine (KIOM).

References

  • 1.Pi-Sunyer X. The medical risks of obesity. Postgraduate Medicine. 2009;121(6):21–33. doi: 10.3810/pgm.2009.11.2074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. Journal of the American Medical Association. 2010;303(3):235–241. doi: 10.1001/jama.2009.2014. [DOI] [PubMed] [Google Scholar]
  • 3.Gargouri Y, Ransac S, Verger R. Covalent inhibition of digestive lipases: an in vitro study. Biochimica et Biophysica Acta. 1997;1344(1):6–37. doi: 10.1016/s0005-2760(97)81102-2. [DOI] [PubMed] [Google Scholar]
  • 4.Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Safety. 2008;31(1):53–65. doi: 10.2165/00002018-200831010-00005. [DOI] [PubMed] [Google Scholar]
  • 5.Jang DS, Lee GY, Kim J, et al. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta. Archives of Pharmacal Research. 2008;31(5):666–670. doi: 10.1007/s12272-001-1210-9. [DOI] [PubMed] [Google Scholar]
  • 6.Slanc P, Doljak B, Kreft S, Lunder M, Janeš D, Štrukelj B. Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Phytotherapy Research. 2009;23(6):874–877. doi: 10.1002/ptr.2718. [DOI] [PubMed] [Google Scholar]
  • 7.Lee H, Ha H, Lee JK, et al. The fruits of Cudrania tricuspidata suppress development of atopic dermatitis in NC/Nga mice. Phytotherapy Research. 2012;26:594–599. doi: 10.1002/ptr.3577. [DOI] [PubMed] [Google Scholar]
  • 8.Shi L, Fu Y. Isolation, purification, and immunomodulatory activity in vitro of three polysaccharides from roots of Cudrania tricuspidata . Acta Biochimica et Biophysica Sinica. 2011;43(5):418–424. doi: 10.1093/abbs/gmr024. [DOI] [PubMed] [Google Scholar]
  • 9.Kim JH, Kim HJ, Park HW, Youn SH, Choi DY, Shin CS. Development of inhibitors against lipase and α-glucosidase from derivatives of monascus pigment. FEMS Microbiology Letters. 2007;276(1):93–98. doi: 10.1111/j.1574-6968.2007.00917.x. [DOI] [PubMed] [Google Scholar]
  • 10.Roh C, Jung U. Screening of crude plant extracts with anti-obesity. International Journal of Molecular Sciences. 2012;13:1710–1719. doi: 10.3390/ijms13021710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kim J, Jang DS, Kim H, Kim JS. Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta . Archives of Pharmacal Research. 2009;32(7):983–987. doi: 10.1007/s12272-009-1702-3. [DOI] [PubMed] [Google Scholar]
  • 12.Galhardo J, Davis N, Matthai S, Shield JP. European Medicines Agency withdrawal for sibutramine. Archives of Disease in Childhood. 2010;95(10):p. 856. doi: 10.1136/adc.2010.190959. [DOI] [PubMed] [Google Scholar]
  • 13.Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nature Reviews Endocrinology. 2010;6(10):578–588. doi: 10.1038/nrendo.2010.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li M, Cheung BMY. Pharmacotherapy for obesity. British Journal of Clinical Pharmacology. 2009;68(6):804–810. doi: 10.1111/j.1365-2125.2009.03453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.de La Garza AL, Milagro FI, Boque N, Campión J, Martínez JA. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Medica. 2011;77(8):773–785. doi: 10.1055/s-0030-1270924. [DOI] [PubMed] [Google Scholar]
  • 16.Bustanji Y, Al-Masri IM, Mohammad M, et al. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba . Journal of Enzyme Inhibition and Medicinal Chemistry. 2011;26(4):453–459. doi: 10.3109/14756366.2010.525509. [DOI] [PubMed] [Google Scholar]
  • 17.Karu N, Reifen R, Kerem Z. Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor. Journal of Agricultural and Food Chemistry. 2007;55(8):2824–2828. doi: 10.1021/jf0628025. [DOI] [PubMed] [Google Scholar]
  • 18.Kim YS, Lee YM, Kim H, et al. Anti-obesity effect of Morus bombycis root extract: anti-lipase activity and lipolytic effect. Journal of Ethnopharmacology. 2010;130(3):621–624. doi: 10.1016/j.jep.2010.05.053. [DOI] [PubMed] [Google Scholar]
  • 19.Lee YM, Kim YS, Lee Y, et al. Inhibitory activities of pancreatic lipase and phosphodiesterase from Korean medicinal plant extracts. Phytotherapy Research. 2012;26:778–782. doi: 10.1002/ptr.3644. [DOI] [PubMed] [Google Scholar]
  • 20.Kang DG, Hur TY, Lee GM, et al. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sciences. 2002;70(22):2599–2609. doi: 10.1016/s0024-3205(02)01547-3. [DOI] [PubMed] [Google Scholar]
  • 21.Lee BW, Lee JH, Gal SW, Moon YH, Park KH. Selective ABTS radical-scavenging activity of prenylated flavonoids from Cudrania tricuspidata . Bioscience, Biotechnology and Biochemistry. 2006;70(2):427–432. doi: 10.1271/bbb.70.427. [DOI] [PubMed] [Google Scholar]
  • 22.Rho YH, Lee BW, Park KH, Bae YS. Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells, at least in part, through the inhibition of DNA topoisomerase I and protein kinase C activity. Anti-Cancer Drugs. 2007;18(9):1023–1028. doi: 10.1097/CAD.0b013e3281de7264. [DOI] [PubMed] [Google Scholar]
  • 23.Zou YS, Hou AJ, Zhu GF. Isoprenylated xanthones and flavonoids from Cudrania tricuspidata . Chemistry and Biodiversity. 2005;2(1):131–138. doi: 10.1002/cbdv.200490164. [DOI] [PubMed] [Google Scholar]
  • 24.Zhao T, Yan GR, Pan SL, Wang HY, Hou AJ. New isoprenylated 2-arylbenzofurans and pancreatic lipase inhibitory constituents from Artocarpus nitidus . Chemistry and Biodiversity. 2009;6(12):2209–2216. doi: 10.1002/cbdv.200900130. [DOI] [PubMed] [Google Scholar]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES